Essam Ghazaly
0000-0003-4368-8565
Medicines and Healthcare Products Regulatory Agency
70 papers found
Refreshing results…
Clofarabine in Combination With High-Dose Cytarabine and Liposomal Daunorubicin in Pediatric Aml: Results of a Phase 1 Combination Study by the Itcc Consortium
Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging
Arginine Deprivation With Pegylated Arginine Deiminase Induces Death Of Acute Myeloid Leukaemia Cells In Vivo
Safety and Pharmacokinetics Of Clofarabine In Combination With High-Dose Cytarabine and Liposomal Daunorubicin In Pediatric AML: Results Of a Phase 1 Combination Study By The ITCC Consortium
ProGem1: Phase I first-in-human study of the novel nucleotide NUC-1031 in adult patients with advanced solid tumors.
Abstract 1885: A comprehensive untargeted UPLC-MS based metabolomic analysis ofASS1-deficient solid tumor cell lines treated with arginine deiminase.
Abstract 4120: T-Cell Dysfunction In CLL Is Mediated Not Only By PD-1/PD-L1 But Also By PD-1/PD-L2 Interactions - Partial Functionality Is Maintained In PD-1 Defined CD8 Subsets and This Can Be Further Promoted By Ibrutinib Treatment
Abstract 1792: The potential role of targeting HER1-4 in bladder cancer
Abstract 3256: Sphingolipid regulation by sphingosine kinase anchoring protein (SKAP) and its implication in cancer
Tracking the Counterfeit and substandard of Ciclosporin Capsules by High Performance Liquid Chromatography
Comparison of three liquid chromatographic techniques (normal, capillary and nano-flow) coupled to triple quadrupole mass spectrometry for targeted absolute quantitative analysis of phosphoinositide 3-kinase/AKT pathway signalling activity
Development and validation of a h.p.l.c. method for ciclosporin: its application to measurement of brand and generic versions from different countries
Combining Her1-4 Targeted Therapies and Chemotherapy in Bladder Cancer
Abstract B139: Arginine deprivation with pegylated arginine deiminase regulates key metabolic genes in RNA and DNA synthesis in ASS1-deficient malignant mesothelioma cells: Clinical implications.
PI3K Inhibition with GDC-0941 Has Greater Efficacy Compared to p110 delta-Selective Inhibition with CAL-101 in Mantle Cell Lymphoma and May Be Particularly Advantageous in Multiply Relapsed Patients
A Synergistic Interaction between Lapatinib and Chemotherapy Agents in a Panel of Cell Lines Is Due to the Inhibition of the Efflux Pump BCRP
Abstract 4489: The activity of novel, potent, selective PI3K/mTOR pathway inhibitors in B-cell malignancies
Accumulation of 2-Hydroxyglutarate (2-Hg) in Normal Karyotype Aml Patients With Idh1 Mutation
Albendazole and its metabolites in the breast milk of lactating women following a single oral dose of albendazole
Development of High Performance Liquid Chromatograph Method for Analysis of Tetracaine for a Tape Stripping Pharmacokinetic Study: A Comparison with Capillary Zone Electrophoresis (CE)
Missing publications? Search for publications with a matching author name.